Skip to content

Clinical trials

Terminated Breast Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: South Korea Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20091
20102
20123
20131
20143
20154
20161
20176
20181
20195
20205
20213
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Odonate Therapeutics, Inc.3
Pfizer3
AstraZeneca2
Genentech, Inc.2
National Cancer Center, Korea2
Sanofi2
AVEO Pharmaceuticals, Inc.1
Amgen1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms40
Neoplasm Metastasis8
Colorectal Neoplasms4
Neoplasms4
Triple Negative Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Head and Neck Neoplasms2
Lung Neoplasms2
Ovarian Neoplasms2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.